- Report
- March 2025
- 180 Pages
Global
From €3359EUR$3,545USD£2,835GBP
€3733EUR$3,939USD£3,150GBP
- Report
- October 2024
- 189 Pages
Global
From €3359EUR$3,545USD£2,835GBP
€3733EUR$3,939USD£3,150GBP
- Report
- October 2024
- 182 Pages
Global
From €3359EUR$3,545USD£2,835GBP
€3733EUR$3,939USD£3,150GBP
- Report
- October 2024
- 187 Pages
Global
From €3359EUR$3,545USD£2,835GBP
€3733EUR$3,939USD£3,150GBP
- Report
- January 2025
- 140 Pages
Global
From €2274EUR$2,400USD£1,919GBP
- Report
- January 2025
- 100 Pages
Global
From €2274EUR$2,400USD£1,919GBP
- Report
- November 2024
- 110 Pages
Global
From €2274EUR$2,400USD£1,919GBP
- Report
- May 2024
- 93 Pages
Global
From €2274EUR$2,400USD£1,919GBP
- Report
- April 2024
- 84 Pages
Global
From €2274EUR$2,400USD£1,919GBP
- Report
- March 2025
- 196 Pages
Global
From €3359EUR$3,545USD£2,835GBP
€3733EUR$3,939USD£3,150GBP
- Report
- November 2024
- 200 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- February 2025
- 100 Pages
Global
From €5638EUR$5,950USD£4,758GBP
- Report
- March 2025
- 185 Pages
Global
From €3359EUR$3,545USD£2,835GBP
€3733EUR$3,939USD£3,150GBP
- Report
- December 2024
- 175 Pages
Global
From €4738EUR$5,000USD£3,999GBP
- Report
- November 2024
- 323 Pages
Global
From €3317EUR$3,500USD£2,799GBP
€4738EUR$5,000USD£3,999GBP
- Report
- July 2024
- 175 Pages
Global
From €4738EUR$5,000USD£3,999GBP
- Report
- March 2025
- 89 Pages
Global
From €5307EUR$5,600USD£4,478GBP
- Report
- March 2025
- 89 Pages
Global
From €5307EUR$5,600USD£4,478GBP
- Report
- March 2025
- 89 Pages
Global
From €5307EUR$5,600USD£4,478GBP
- Report
- March 2025
- 93 Pages
Global
From €5307EUR$5,600USD£4,478GBP

The Clinical Development market is a key component of the Drug Discovery process. It involves the testing of new drugs and treatments on human subjects in order to assess their safety and efficacy. Clinical Development typically involves a series of phases, beginning with pre-clinical trials and progressing through to Phase I, II, and III clinical trials. The results of these trials are used to determine whether a drug should be approved for use by regulatory authorities.
The Clinical Development market is highly competitive, with a range of companies offering services such as clinical trial design, data management, and regulatory consulting. These companies are often specialized in specific therapeutic areas, such as oncology, neurology, and cardiology. Examples of companies in the Clinical Development market include Parexel, ICON, and Syneos Health. Show Less Read more